Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses CATY Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction AKR Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher CENT Q1 2026 Earnings Strong Profitability Despite Headwinds EPS Surges Past Estimates RBLX Q1 2026 Earnings EPS Beat Drives Positive Market Reaction IMNN Q1 2026 Earnings Narrowing Losses Beat Street Expectations as Pipeline Progress Continues